January 27, 2020
by David Yasvinski, The Growth Op
Rapid Dose Therapeutics (RDT) is going back to school.
The Ontario-based company has partnered with McMaster University — and secured a $540,000 grant from the Canadian government — to advance its drug delivery system by developing “novel biopolymer compositions” that facilitate the absorption of cannabis and other medications through oral dissolvable thin films.
“RDT is committed to playing a leadership role in the development of innovative solutions for delivering active ingredients to patients and consumers in health and wellness, medical cannabis and pharmaceutical markets,” said Rina Carlini, the company’s vice president of research and innovation.
To view the full story, please click here.
Sign up for Oral Health Group’s weekly e-newsletter to have news delivered straight to your inbox!
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.